Provention bio to report first quarter 2021 financial results on may 6, 2021

Red bank, n.j., april 29, 2021 /prnewswire/ -- provention bio, inc. (nasdaq: prvb), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated disease, today announced that it will report its first quarter 2021 financial results on thursday, may 6, 2021, before the opening of the u.s. financial markets.
PRVB Ratings Summary
PRVB Quant Ranking